Callan Family Office’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Buy
18,452
+422
+2% +$19.5K 0.02% 637
2026
Q1
$884K Sell
18,030
-1,648
-8% -$76.7K 0.02% 598
2025
Q4
$858K Buy
19,678
+3,697
+23% +$169K 0.02% 592
2025
Q3
$719K Sell
15,981
-2,094
-12% -$92K 0.02% 442
2025
Q2
$785K Buy
18,075
+12,306
+213% +$548K 0.02% 454
2025
Q1
$266K Sell
5,769
-598
-9% -$25K 0.02% 453
2024
Q4
$240K Buy
+6,367
New +$247K 0.02% 555

Other funds holding EXC

Callan Family Office's EXC Position: Q2 2026 in Review

Callan Family Office increased its Exelon (EXC) stake by 2.3% in Q2 2026, buying an estimated $19.5K and bringing the position to 18,452 shares worth $860K. The position accounts for 0.02% of the portfolio, ranked #637.

Callan Family Office first reported a position in EXC in Q4 2024 and has held it in 7 quarters since. The position peaked at $884K in Q1 2026. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Callan Family Office held 18,452 shares of Exelon worth $860K as of Q2 2026.
  • Callan Family Office bought 422 Exelon shares in Q2 2026, an estimated $19.5K.
  • Exelon made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #637 holding.
  • Callan Family Office first reported a position in Exelon in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Exelon position peaked at $884K in Q1 2026.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.